AUSTIN, Texas, Sept. 16, 2024 /PRNewswire/ -- Alafair Biosciences is proud to announce that it has been selected to exhibit its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), at the Vizient ...

本研究针对全踝关节置换术(TAR)后常见的围假体瘢痕和异位骨形成问题，创新性地采用透明质酸(HA)藻酸盐水凝胶(VersaWrap)进行术中干预。美国Hancock Health医疗中心的研究团队通过69岁女性病例证实，该技术能有效维持术后关节活动度(ROM)，使VAS疼痛评分从10降至1 ...

Alafair Biosciences, Inc., a privately held medical device company, announced that its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), has been awarded a national group purchasing agreement ...

AUSTIN, Texas, Dec. 19, 2024 /PRNewswire/ -- Alafair Biosciences announced today that it has surpassed 22,000 patient implants of its flagship product, VersaWrap Hydrogel Sheet, marking a significant ...

AUSTIN, Texas, May 23, 2019 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that sales of its initial product, VersaWrap® Tendon Protector (VersaWrap), ...

AUSTIN, Texas, Nov. 21, 2023 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that surgeons have implanted over 12,000 units of its flagship product, ...

AUSTIN, Texas--(BUSINESS WIRE)--Alafair Biosciences Inc., an emerging medical device company, announced today that it received 510(k) clearance from the FDA to market and sell its tendon product, ...

AUSTIN, Texas, April 1, 2025 /PRNewswire/ -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that Alafair Biosciences ...